Navidea Biopharmaceuticals Incの債務/株式
Navidea Biopharmaceuticals Incの債務/株式は何ですか。
Navidea Biopharmaceuticals Incの債務/株式は-0.24です。
債務/株式の定義は何ですか。
負債比率は、株主資本と企業資産の融資に使用される負債の相対的割合を示す財務比率です。
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
NYSEMKTのセクタHealth Careにおける債務/株式の企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似の債務/株式
- Emisphere Technologiesの債務/株式は-0.42です。
- Adamis Pharmaceuticals Corpの債務/株式は-0.41です。
- Orca Goldの債務/株式は-0.36です。
- CBD Global Sciencesの債務/株式は-0.33です。
- Adynxxの債務/株式は-0.26です。
- Orsu Metalsの債務/株式は-0.26です。
- Navidea Biopharmaceuticals Incの債務/株式は-0.24です。
- Insurance Acquisitionの債務/株式は-0.22です。
- RJK Explorationsの債務/株式は-0.17です。
- Inspire Semiconductorの債務/株式は-0.13です。
- Cytocom Incの債務/株式は-0.10です。
- Curative Biosciencesの債務/株式は-0.10です。
- Supreme Metals Corpの債務/株式は-0.07です。